Oxcarbazepine Tablet, Film Coated
Product Images NDC 70518-3940

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 70518-3940). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

FDA Label Image

Oxcarbazepinetabfig1 (Oxcarbazepinetabfig1)

Oxcarbazepinetabfig1 (Oxcarbazepinetabfig1)
The text provided mentions the "log-rank test" with a p-value of 0.0001. It also includes a table with "Day2" and "Day 11" along with a "Treatment Group" named "Oxcarbarspine".*
FDA Label Image

Oxcarbazepinetabfig2 (Oxcarbazepinetabfig2)

FDA Label Image

Oxcarbazepinetabfig3 (Oxcarbazepinetabfig3)

Oxcarbazepinetabfig3 (Oxcarbazepinetabfig3)
The given text appears to be the results of a statistical test called the log-rank test. The p-value of the test is 0.0001, indicating a highly significant result. There are also some numbers listed in a table-like format, possibly representing different time points or measurements. The text also mentions a "Treatment Group" with "HIGH" and "LOW" categories, which might refer to different treatment conditions being compared. However, due to the inclusion of non-English characters and unclear formatting, it is difficult to determine the exact meaning and context of the provided text.*
FDA Label Image

Oxcarbazepinetabfig4 (Oxcarbazepinetabfig4)

Oxcarbazepinetabfig4 (Oxcarbazepinetabfig4)
The text suggests that a statistical test called the 0.9+ log-rank test was conducted, resulting in a significant p-value of 0.0001. The remaining text seems to refer to a graph or data related to "Time to exit (days)" in a treatment group labeled "HIGH - LOW." Overall, it appears to be a description of a study or experiment, but without additional context, it is difficult to provide a more specific description.*
FDA Label Image

Oxcarbazepinetabstruct (Oxcarbazepinetabstruct)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.